Search

Author/Creator Lindner, Christoph

3. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Issue 5 (May 2022)

Authors:
Nitz, Ulrike; Gluz, Oleg; Graeser, Monika; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Braun, Michael; Augustin, Doris; Potenberg, Jochem; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; zu Eulenburg, Chris...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 5(2022)
Page Start:
625
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients. Issue 8 (2nd April 2019)

Authors:
Nabieva, Naiba; Häberle, Lothar; Brucker, Sara Y.; Janni, Wolfgang; Volz, Bernhard; Loehberg, Christian R.; Hartkopf, Andreas D.; Walter, Christina‐Barbara; Baake, Gerold; Fridman, Alexander; Malter, Wolfram; Wuerstlein, Rachel; Harbeck, Nadia; Hoffmann, Oliver; Kuemmel, Sherko; Martin, Bernhard;...
Journal:
International journal of cancer
Issue:
Volume 145:Issue 8(2019)
Page Start:
2114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗